R. Hector Mackay-dunn - Net Worth and Insider Trading
R. Hector Mackay-dunn Net Worth
The estimated net worth of R. Hector Mackay-dunn is at least $97,996 dollars as of 2024-06-05. R. Hector Mackay-dunn is the Director of Aurinia Pharmaceuticals Inc and owns about 18,595 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $97,996. Details can be seen in R. Hector Mackay-dunn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R. Hector Mackay-dunn has not made any transactions after 2024-05-21 and currently still holds the listed stock(s).
Transaction Summary of R. Hector Mackay-dunn
R. Hector Mackay-dunn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R. Hector Mackay-dunn owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of R. Hector Mackay-dunn’s form 4 insider trades.
Insider Ownership Summary of R. Hector Mackay-dunn
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | director |
R. Hector Mackay-dunn Latest Holdings Summary
R. Hector Mackay-dunn currently owns a total of 1 stock. R. Hector Mackay-dunn owns 18,595 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 21, 2024, with a value of $97,996.
Latest Holdings of R. Hector Mackay-dunn
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | 18,595 | 5.27 | 97,996 |
Holding Weightings of R. Hector Mackay-dunn
R. Hector Mackay-dunn Form 4 Trading Tracker
According to the SEC Form 4 filings, R. Hector Mackay-dunn has made a total of 3 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 5,630 shares on May 21, 2024, which brought R. Hector Mackay-dunn around $32,316.
Insider Trading History of R. Hector Mackay-dunn
- 1
R. Hector Mackay-dunn Trading Performance
GuruFocus tracks the stock performance after each of R. Hector Mackay-dunn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R. Hector Mackay-dunn is 6.15%. GuruFocus also compares R. Hector Mackay-dunn's trading performance to market benchmark return within the same time period. The performance of stocks bought by R. Hector Mackay-dunn within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R. Hector Mackay-dunn's insider trading performs compared to the benchmark.
Performance of R. Hector Mackay-dunn
R. Hector Mackay-dunn Ownership Network
Ownership Network List of R. Hector Mackay-dunn
Ownership Network Relation of R. Hector Mackay-dunn
R. Hector Mackay-dunn Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
R. Hector Mackay-dunn is the director of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include director & Chief Executive Officer Peter Greenleaf , Chief Financial Officer Joseph M Miller , and Ex VP & Intern'l Operations Matthew Maxwell Donley .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, R. Hector Mackay-dunn made 2 insider transaction in Aurinia Pharmaceuticals Inc (AUPH) with a net sale of 10,448. Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 192,778 shares made by Peter Greenleaf , a net sale of 96,791 shares made by Stephen P. Robertson , and a net sale of 57,505 shares made by Joseph M Miller .
In summary, during the past 3 months, insiders sold 299,937 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 299,937 shares. During the past 18 months, 496,705 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 476,705 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
R. Hector Mackay-dunn Mailing Address
Above is the net worth, insider trading, and ownership report for R. Hector Mackay-dunn. You might contact R. Hector Mackay-dunn via mailing address: #1203-4464 Markham Street, Victoria A1 V8z7x8.